(S)-2-((7H-purin-6-ylamino)(cyclopropyl)methyl)-5-amino-3-phenylquinazolin-4(3H)-one

ID: ALA4858100

Chembl Id: CHEMBL4858100

PubChem CID: 137540911

Max Phase: Preclinical

Molecular Formula: C23H20N8O

Molecular Weight: 424.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Nc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12

Standard InChI:  InChI=1S/C23H20N8O/c24-15-7-4-8-16-17(15)23(32)31(14-5-2-1-3-6-14)22(29-16)18(13-9-10-13)30-21-19-20(26-11-25-19)27-12-28-21/h1-8,11-13,18H,9-10,24H2,(H2,25,26,27,28,30)/t18-/m0/s1

Standard InChI Key:  IQDBKFTVYYBTJD-SFHVURJKSA-N

Alternative Forms

1. Parent:

   

   ALA4858100

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 424.47

Molecular Weight (Monoisotopic): 424.1760

AlogP: 3.20

#Rotatable Bonds: 5

Polar Surface Area: 127.40

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 10.19

CX Basic pKa: 3.59

CX LogP: 2.90

CX LogD: 2.90

Aromatic Rings: 5

Heavy Atoms: 32

QED Weighted: 0.37

Np Likeness Score: -0.88

References

1. Kim YS, Cheon MG, Boggu PR, Koh SY, Park GM, Kim G, Park SH, Park SL, Lee CW, Kim JW, Jung YH..  (2021)  Synthesis and biological evaluation of novel purinyl quinazolinone derivatives as PI3Kδ-specific inhibitors for the treatment of hematologic malignancies.,  45  [PMID:34332211] [10.1016/j.bmc.2021.116312]

Source

Source(1):

• Scientific Literature